Prophylactic Antiviral Treatment in Recurrent Herpes Zoster: A Case Report

Basit Öğe Kaydı
dc.authoridBayindir, Yasar/0000-0003-3930-774X
dc.authorwosidOzcan, Hamdi/T-8408-2019
dc.authorwosidBayindir, Yasar/T-1523-2017
dc.contributor.authorBayram, Hatice Gamze
dc.contributor.authorOzcan, Hamdi
dc.contributor.authorBayindir, Yasar
dc.date.accessioned2024-08-04T20:32:54Z
dc.date.available2024-08-04T20:32:54Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractHerpes zoster (HZ) occurs in older ages with activation of varicella-zoster virus (VZV) which persists in a dormant phase within the dorsal root ganglia. The incidence of HZ in immunosuppressed patients is 20-100 times higher and the clinical progress is more severe than in immunocompetent individuals. A 48-year-old man who had been diagnosed with acute myelocytic leukemia type M3 and had been treated with immunosuppressive agents was admitted to our clinic. The patient was clinically diagnosed as having HZ. He was treated with acyclovir 800 mg five times daily for 7 days. In the consecutive three months, he attended our clinic again with similar complaints. The left cervical (C)5, C6 dermatomes were involved at the fourth attack of HZ. Multinucleated giant cells were determined on the Tzanck smear. VZV DNA was detected by polymerase chain reaction (PCR). Treatment with valacyclovir 1 g three times daily for 14 days was prescribed and then, prophylactic treatment with valacyclovir 500 mg two times a day was administered. Although immunosuppressive treatment was continued, no new attacks of herpes zoster occurred. We think that prophylactic antiviral therapy should be initiated in immunosuppressive individuals who have recurrent herpes zoster attacks.en_US
dc.identifier.doi10.4274/turkderm.45.26
dc.identifier.endpage59en_US
dc.identifier.issn2717-6398
dc.identifier.issn2651-5164
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-79960166310en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage56en_US
dc.identifier.urihttps://doi.org/10.4274/turkderm.45.26
dc.identifier.urihttps://hdl.handle.net/11616/95379
dc.identifier.volume45en_US
dc.identifier.wosWOS:000209157100013en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofTurkderm-Turkish Archives of Dermatology and Venerologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHerpes zosteren_US
dc.subjectrecurrenten_US
dc.subjectprophylactic treatmenten_US
dc.subjectimmunosuppressionen_US
dc.titleProphylactic Antiviral Treatment in Recurrent Herpes Zoster: A Case Reporten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu